Literature DB >> 30506166

Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance.

José M Porcel1, Irene Cuadrat2, Tomás García-Cerecedo3, Marina Pardina4, Silvia Bielsa2.   

Abstract

PURPOSE: Pleural effusion (PEs) may complicate diffuse large B-cell lymphomas (DLBCL). However, their real prevalence and prognostic significance have seldom been approached systematically.
METHODS: Retrospective single-center evaluation of consecutive patients with DLBCL was conducted. Baseline characteristics, PEs on CT imaging, pleural fluid analyses, and outcome until death or censoring date were collected.
RESULTS: Of 185 DLBCL patients, 55 (30%) had PEs, of which 27 (49%) were analyzed. Most tapped PEs were malignant (n = 24) and cytological and/or flow cytometric analyses provided the diagnosis in about 70% of the cases. Malignant PEs were exudates with adenosine deaminase levels > 35 U/L in 35% of the cases. More than one-third of lymphomatous PEs required definitive pleural procedures for symptomatic relief. PEs greater than 200 mL on CT scans were an independent predictor of poor survival in Cox regression modeling (hazard ratio 1.9).
CONCLUSIONS: PEs are common in DLBCL and foreshadow a poor prognosis.

Entities:  

Keywords:  Adenosine deaminase; Chylothorax; Diffuse large B-cell lymphoma; Indwelling pleural catheter; Pleural effusion; Pleurodesis; Survival

Mesh:

Year:  2018        PMID: 30506166     DOI: 10.1007/s00408-018-0182-y

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  18 in total

1.  Malignant effusions correlate with poorer prognosis in patients with diffuse large B-cell lymphoma.

Authors:  Ya-Ping Chen; Huai-Yi Huang; Kun-Piao Lin; L Jeffrey Medeiros; Tsai-Yun Chen; Kung-Chao Chang
Journal:  Am J Clin Pathol       Date:  2015-05       Impact factor: 2.493

2.  Persistent benign pleural effusion.

Authors:  J M Porcel
Journal:  Rev Clin Esp (Barc)       Date:  2017-05-04

3.  Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.

Authors:  Chieh-Sheng Lu; Jia-Hong Chen; Tzu-Chuan Huang; Yi-Ying Wu; Ping-Ying Chang; Ming-Shen Dai; Yeu-Chin Chen; Ching-Liang Ho
Journal:  Leuk Lymphoma       Date:  2015-01-14

4.  Early death in patients diagnosed with non-Hodgkin's lymphoma.

Authors:  Osnat Bairey; Michal Bar-Natan; Ofer Shpilberg
Journal:  Ann Hematol       Date:  2012-11-17       Impact factor: 3.673

5.  Investigating unilateral pleural effusions: the role of cytology.

Authors:  David T Arnold; Duneesha De Fonseka; Siobhan Perry; Anna Morley; John E Harvey; Andrew Medford; Mary Brett; Nick A Maskell
Journal:  Eur Respir J       Date:  2018-11-08       Impact factor: 16.671

6.  Malignant pleural effusions in lymphoproliferative disorders.

Authors:  Shahid Ahmed; Rabia K Shahid; Rola Rimawi; Anita K Siddiqui; Leonard Rossoff; Cristina P Sison; Harry Steinberg; Kanti R Rai
Journal:  Leuk Lymphoma       Date:  2005-07

7.  B cell lymphoma with lung involvement: what is it about?

Authors:  Michael Mian; Ines Wasle; Stefan Gritsch; Wolfgang Willenbacher; Michael Fiegl
Journal:  Acta Haematol       Date:  2014-11-04       Impact factor: 2.195

8.  Clinical features and survival of lung cancer patients with pleural effusions.

Authors:  Jose M Porcel; Ariadna Gasol; Silvia Bielsa; Carme Civit; Richard W Light; Antonieta Salud
Journal:  Respirology       Date:  2015-02-23       Impact factor: 6.424

9.  Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases.

Authors:  Camille Laurent; Catherine Do; Pierre-Antoine Gourraud; Geisilene Russano de Paiva; Séverine Valmary; Pierre Brousset
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

10.  Diagnostic pitfalls of discriminating lymphoma-associated effusions.

Authors:  Hung-Jen Chen; Kuo-Yang Huang; Guan-Chin Tseng; Li-Hsiou Chen; Li-Yuan Bai; Shinn-Jye Liang; Chih-Yen Tu; Richard W Light
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

View more
  3 in total

Review 1.  Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Authors:  Francesca Sanguedolce; Magda Zanelli; Maurizio Zizzo; Alessandra Bisagni; Alessandra Soriano; Giorgia Cocco; Andrea Palicelli; Giacomo Santandrea; Cecilia Caprera; Matteo Corsi; Giulia Cerrone; Raffaele Sciaccotta; Giovanni Martino; Linda Ricci; Francesco Sollitto; Domenico Loizzi; Stefano Ascani
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

Review 2.  Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis.

Authors:  Yuan Yang; Juan Du; Yi-Shan Wang; Han-YuJie Kang; Kan Zhai; Huan-Zhong Shi
Journal:  Clin Transl Sci       Date:  2022-03-21       Impact factor: 4.438

3.  Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer.

Authors:  José M Porcel; Paola Murata; Laura Porcel; Silvia Bielsa; Marina Pardina; Antonieta Salud
Journal:  Pleura Peritoneum       Date:  2021-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.